The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Joshua Woolley, MD, PhD
- Principal investigator
- Joshua Woolley, MD,PhD
- Start date
- 2024-08-19
- End date
- 2028-06-01
- Registry ID
- NCT06455293
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.